Kate Robinson
Assistant Editor
Kate graduated from Sheffield Hallam University with a bachelor's degree in biomedical sciences in 2020. During her studies she developed a passion for science communication and after graduating, began a science blog in order to continue writing about trending science news and topics of interest. She joined the editorial team at Technology Networks in 2021. In her role as assistant editor Kate supports the publication’s in-house writers, produces scientific content across all communities and works closely with the managing editor to help coordinate commissioned pieces.
Latest Content
News
Green Tea Compound May Prevent and Treat Uterine Fibroids
According to research, a green tea compound called epigallocatechin gallate could be promising for both preventing and treating uterine fibroids.
News
Long COVID Risk Reduced by Common Diabetes Drug
Metformin, a drug commonly used to treat diabetes, can reduce the risk of developing long COVID by over 40%, according to a study.
Infographic
Cell Therapy
This infographic explores how cell therapies can be made and the potential diseases that they are, and could be, used to treat.
Industry Insight
Increasing Throughput While Protecting Proteome Coverage
At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.
Article
Protein Hyperactivation Could Kill Cancer Cells and Bacteria
Technology Networks had the pleasure of speaking with Walid A. Houry, professor of biochemistry at the University of Toronto, to find out about the discovery of compounds that can induce protease hyperactivation to kill cancer cells.
Industry Insight
Small Molecule KRAS Inhibitors With Potent Antitumor Activity
In this interview, Technology Networks spoke to Dr. Cameron Pitt to learn more about KRAS as a target for cancer therapeutics, avoiding known resistance mechanisms and the effectiveness of two novel KRAS inhibitors.
Article
Where Is ICP-MS Making a Difference?
Inductively coupled plasma-mass spectrometry (ICP-MS) is an analytical technique that can be used across a broad range of applications, a few of which we will explore here.
Industry Insight
A Non-Invasive Treatment for Difficult-To-Treat Pediatric Brain Cancer
In this interview, Technology Networks spoke to Dr. Stuart Marcus, founder and chief medical officer of SonALAsense, to find out how ALA sonodynamic therapy could be a more effective treatment for diffuse intrinsic pontine glioma and recurrent glioblastoma.
News
Drug With Potential To Ease Pain in Osteoarthritis Moves to Clinical Trial
Results from an animal study published in Science Translational Medicine demonstrate that a drug compound can disrupt overactivation of inflammation and manage pain and stiffness in osteoarthritis. The drug will be tested in upcoming Phase I and IIa clinical trials.
News
Could Viruses Help in the Fight Against Antibiotic Resistance?
A study published in Nature Chemical Biology suggests that a new bacteriophage screening approach could assist scientists attempting to overcome antibiotic resistance.
Advertisement
